- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05576402
Endoscopic Scoring System Utilization in Inflammatory Bowel Disease
December 26, 2022 updated by: Juan Lasa, Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
Endoscopic Scoring System Utilization for Inflammatory Bowel Disease Activity Assessment
Inflammatory bowel diseases comprise two distinctive entities: Crohn's disease and ulcerative colitis.
During the last decade, endoscopic assessment of inflammation has become relevant since it is a prognostic factor.
As a consequence, therapeutic targets now contemplate mucosal healing as part of the goals to be achieved.
Endoscopic scores for Crohn's disease and ulcerative colitis have been developed to objectively assess the mucosal inflammatory activity.
Although they may have some limitations, these scores have been widely accepted in referral centers, especially since they have been adopted as standard evaluation in inflammatory bowel disease clinical trials .
However, their use in the setting of endoscopic practice outside centers with a high volume or with less experience in clinical trials is not known.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
1500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Juan S Lasa, MD
- Phone Number: 541140848182
- Email: juanselasa@gmail.com
Study Locations
-
-
-
Buenos Aires, Argentina, 1425
- Recruiting
- Cemic
-
Contact:
- Juan S Lasa, MD
- Phone Number: 541140848182
- Email: drjuanslasa@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Adult patients who have already received a diagnosis of either Crohn's disease or ulcerative colitis
Description
Inclusion Criteria:
- Adult patients who underwent colonoscopy for the evaluation of mucosal inflammatory activity
- Patients with an established diagnosis of either Crohn's disease or ulcerative colitis
Exclusion Criteria:
- Sigmoidoscopies performed in ulcerative colitis for the assessment of mucosal inflammatory activity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Endoscopic score report
Time Frame: January 2018-October 2022
|
Proportion of colonoscopy reports among inflammatory bowel disease patients which include an endoscopic score to assess inflammatory activity
|
January 2018-October 2022
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Juan S Lasa, MD, Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 2, 2022
Primary Completion (Anticipated)
January 31, 2023
Study Completion (Anticipated)
February 20, 2023
Study Registration Dates
First Submitted
October 8, 2022
First Submitted That Met QC Criteria
October 8, 2022
First Posted (Actual)
October 12, 2022
Study Record Updates
Last Update Posted (Actual)
December 28, 2022
Last Update Submitted That Met QC Criteria
December 26, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 333
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammatory Bowel Diseases
-
University of British ColumbiaCompletedInflammatory Bowel Disease 11Canada
-
University of ChicagoTerminatedInflammatory Bowel Disease (IBD)United States
-
Centre Hospitalier Universitaire, AmiensFunding from DGOS (PHRC IR 2013 and PRME)CompletedPediatric Inflammatory Bowel DiseaseFrance
-
University of Wisconsin, MadisonTerminatedInflammatory Bowel Disease (IBD)United States
-
Cedars-Sinai Medical CenterUnknownPediatric Inflammatory Bowel Disease
-
University of Wisconsin, MadisonCompletedInflammatory Bowel Disease (IBD)United States
-
Assiut UniversityNot yet recruitingIBD-Inflammatory Bowel Disease
-
Icahn School of Medicine at Mount SinaiNorthwestern University; The Cleveland Clinic; University of California, Davis; RxHealt...RecruitingInflammatory Bowel Disease (IBD)United States
-
Nemours Children's ClinicNASPGHAN FoundationCompletedInflammatory Bowel Disease (IBD)United States
-
Hull University Teaching Hospitals NHS TrustWellcome/EPSRC Centre for Interventional and Surgical Sciences, University...RecruitingInflammatory Bowel Disease 1United Kingdom
Clinical Trials on colonoscopy
-
East Bay Institute for Research and EducationCompleted
-
Indiana UniversityCompletedColorectal NeoplasmsUnited States
-
University of NaplesCompletedAdenomatous PolypsItaly
-
University of Southern CaliforniaTerminatedGastrointestinal HemorrhageUnited States
-
University of CalgaryCompletedInflammatory Bowel DiseaseCanada
-
Indiana UniversityCompletedPolypsUnited States
-
Tokyo UniversityCompleted
-
Vestre Viken Hospital TrustUllevaal University Hospital; Ostfold Hospital Trust; Sahlgrenska University...Not yet recruitingColorectal Cancer | Colorectal Neoplasia | Screening Colonoscopy | Colorectal Cancer Screening | Vasovagal Reaction
-
Dr. Horst Schmidt Klinik GmbHCompletedAdenoma | Colo-rectal CancerGermany
-
The University of Texas Health Science Center,...WithdrawnColorectal NeoplasmsUnited States